K-Dur Applies To Authorized Generic Deals, FTC Insists

Law360, New York (October 9, 2012, 6:37 PM EDT) -- The Federal Trade Commission on Friday once again urged a federal court to apply the Third Circuit's recent K-Dur ruling on pay-for-delay deals to a case targeting an authorized generic settlement, this time in a putative class action against GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd.

The antitrust watchdog lodged a proposed amicus brief with the New Jersey federal court overseeing a case that accuses GSK and Teva of conspiring to keep a generic version of epilepsy drug Lamictal off the market in order to maximize...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.